iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Solis Mammography to define cardiovascular risk. The development and commercial collaboration revolves around producing an artificial intelligence (AI) solution. This solution potentially quantifies the presence of breast arterial calcifications in a mammogram to assess the risk of cardiovascular disease (CVD). It uses data obtained […]
Mammography
Sidekick Health and Eli Lilly partner on digital therapeutics for breast cancer
Sidekick Health today announced a collaboration on an integrated digital therapeutics solution in conjunction with Eli Lilly (NYSE:LLY). The collaboration between the companies will mark the first phase of a relationship between Sidekick and Lilly, which starts with a digital therapeutic offering for patients battling breast cancer. According to a news release, the first phase […]
OncoRes Medical raises another $12.5M
OncoRes Medical announced that it raised $12.5 million for its handheld imaging device for identifying cancer cells. Perth, Western Australia-based OncoRes designed its imaging system to facilitate real-time tumor assessment, helping surgeons more accurately identify and remove cancerous tissue, including for breast cancer. The company won FDA breakthrough device designation in October 2020 for the […]
Delphinus wins FDA approval for whole breast ultrasound tomography system
Delphinus Medical Technologies announced today that it received FDA premarket approval (PMA) for its SoftVue system. Novi, Michigan-based Delphinus develops the SoftVue 3D whole breast ultrasound tomography system for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue, according to a news release. The company said SoftVue […]
Fujifilm integrates two of its medical businesses
Fujifilm Medical Systems U.S.A. and Fujifilm Healthcare Americas announced last week that the two companies have merged. Now operating under the name Fujifilm Healthcare Americas Corp., the new combination of organizations aims to bring together the strengths of each company’s product portfolios and employees to create new value for customers and advance medical care, according […]
Latest iCad 3D mammography AI gains CE mark
iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval. Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level, and approximately 40% faster processing on the new […]
Ibex AI-enabled breast cancer diagnostic lands CE mark
Ibex Medical Analytics announced today that it received CE mark approval for its Galen AI-based breast cancer diagnostic platform. Tel Aviv, Israel–based Ibex’s Galen platform uses AI and machine learning technology based on hundreds of thousands of image samples scanned from biopsy slides through digital pathology, according to a news release. Galen previously won CE […]
SmartBreast, FITI partner for molecular breast imaging system manufacturing
SmartBreast today announced it has forged a partnership with FoxSemicon Integrated Technologies (FITI) to manufacture molecular breast imaging systems. FITI will be the contract manufacturer of the two molecular breast imaging systems recently acquired by SmartBreast, the GE Healthcare Discovery NM750b and the Dilon Technologies D6800. SmartBreast previously announced that it would be rebranding the […]
GE Healthcare sells molecular breast imaging assets to SmartBreast
SmartBreast today announced that it has acquired GE Healthcare (NYSE:GE)’s molecular breast imaging assets for an undisclosed amount. The Pittsburgh-based company acquired the Discovery NM750b and other MBI scanner designs, manufacturing tools, instructions and related patents and installed-base service business as part of the deal. SmartBreast will begin to market and distribute the Discovery NM750b and […]
GE Healthcare debuts breast cancer tech
GE Healthcare (NYSE:GE) announced today that it made the Serena Bright biopsy technology available in the U.S. Chicago-based GE Healthcare touts Serena Bright as the industry’s first contrast-enhanced guided biopsy solution, according to a news release. The technology is designed to help clinicians and patients in the fight against breast cancer. Serena Bright received FDA 510(k) […]
FDA clears Zebra Medical’s AI tool for mammograms
Zebra Medical Vision announced that it received FDA 510(k) clearance for its HealthMammo mammography algorithm technology. Shefayim, Israel-based Zebra Medical Vision develops the system, which already has CE Mark approval, to allow breast radiologists to prioritize and identify suspicious mammograms, providing a safety net for radiologists and offering faster reads on mammograms than the current […]